Molecular mechanism of Panlongqi Tablets in ameliorating rheumatoid arthritis by suppressing PI3K-AKT-GSK-3β signaling pathway-mediated inflammatory responses
1.Shaanxi Provincial and Ministerial Co-constructed Collaborative Innovation Center for Industrialization of Traditional Chinese Medicine Resources, Shaanxi University of Chinese Medicine, Xianyang 712083, China
2.Beijing University of Chinese Medicine, Beijing 100700, China
3.Shaanxi Panlong Pharmaceutical Group Co., Ltd., Shangluo 711400, China
4.Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China
收起